BioCryst Pharmaceuticals Inc. (BCRX)

3.32
NASDAQ : Health Technology
Prev Close 3.54
Day Low/High 3.29 / 3.53
52 Wk Low/High 3.10 / 9.95
Avg Volume 1.52M
Exchange NASDAQ
Shares Outstanding 110.31M
Market Cap 390.51M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)
First Week of February 20th Options Trading For BioCryst Pharmaceuticals (BCRX)

First Week of February 20th Options Trading For BioCryst Pharmaceuticals (BCRX)

Investors in BioCryst Pharmaceuticals, Inc. saw new options become available this week, for the February 20th expiration.

First Week of BCRX September 18th Options Trading

First Week of BCRX September 18th Options Trading

Investors in BioCryst Pharmaceuticals, Inc. saw new options begin trading this week, for the September 18th expiration.

Perilous Reversal Stock: Biocryst Pharmaceuticals (BCRX)

Perilous Reversal Stock: Biocryst Pharmaceuticals (BCRX)

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a "perilous reversal" (up big yesterday but down big today) candidate

'Mad Money' Lightning Round: GE Is a Good Stock With Good Yield

'Mad Money' Lightning Round: GE Is a Good Stock With Good Yield

Cramer is skittish on Sanofi, can't recommend C&J Energy Services and doesn't want you in Annaly Capital.

Jim Cramer's 'Mad Money' Recap: Why This Market Is All About Velocity

Jim Cramer's 'Mad Money' Recap: Why This Market Is All About Velocity

A day's rest from the selling in oil will allow investors, analysts and oil companies themselves some time to assess their situations, Cramer says.

December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey

December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey

A cheat sheet of earnings, medical meetings, FDA approval decisions and clinical trial results for health care investors.

BCRX Crosses Below Key Moving Average Level

BCRX Crosses Below Key Moving Average Level

In trading on Wednesday, shares of BioCryst Pharmaceuticals, Inc. crossed below their 200 day moving average of $11.03, changing hands as low as $10.88 per share.

Ebola Linked Names Rise Again Amid Broader Market Sell-Off

Ebola Linked Names Rise Again Amid Broader Market Sell-Off

Shares of companies leveraged to Ebola are rising again after a second health care worker in the U.S. tested positive for the illness.

Strong On High Relative Volume: Biocryst Pharmaceuticals (BCRX)

Strong On High Relative Volume: Biocryst Pharmaceuticals (BCRX)

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a strong on high relative volume candidate

Lakeland Industries Continues To Surge Amid Ebola Fears

Lakeland Industries Continues To Surge Amid Ebola Fears

Shares of Lakeland Industries, which supplies protective clothing to the Centers for Disease Control and other governmental agencies, are soaring amid continued fears over the Ebola outbreak...

Ebola Outbreak Puts the Spotlight on 10 Biotech Companies

Ebola Outbreak Puts the Spotlight on 10 Biotech Companies

The Ebola outbreak has put the spotlight on Chimerix as well as other biotech companies with potential vaccines and even those stocks with marginal relation to the virus.

Perilous Reversal Stock: Biocryst Pharmaceuticals (BCRX)

Perilous Reversal Stock: Biocryst Pharmaceuticals (BCRX)

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a "perilous reversal" (up big yesterday but down big today) candidate

Biocryst Pharmaceuticals (BCRX) Marked As A Barbarian At The Gate

Biocryst Pharmaceuticals (BCRX) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks

Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks

Ebola lands in Texas, so expect some crazy volatility Wednesday in biotech and drug stocks.

Heavy Early Morning Activity On Biocryst Pharmaceuticals (BCRX)

Heavy Early Morning Activity On Biocryst Pharmaceuticals (BCRX)

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a pre-market mover with heavy volume candidate

TheStreet Quant Rating: D- (Sell)